We have isolated a chymotrypsin-like and a trypsin-like proteinase from human dermis; these enzymes are probably of mast cell origin. We will: 1. Refine purification methods and further characterize the physical, chemical and kinetic properties of these enzymes. 2. Produce antibodies to these enzymes and use them for radioimmunoassays and immunocytological investigations. 3. Localize these proteinases in tissue at the light and ultrastructural level and determine their relationship to mast cells. 4. Prepare enriched mast cell populations and investigate whether the enzymes are secreted along with other mast cell mediators. We will also determine whether these enzymes are secreted by mast cells in vivo. 5. Investigate the proteins cleaved by the chymotrypsin-like proteinase in basement membrane which will probe the nature of basement membrane. 6. Study the role of the chymotrypsin-like proteinase disease in cutaneous disease with special attention to cutaneous mast cell disease and bullous pemphigoid. We have demonstrated that psoriatic epidermis has increased levels of plasminogen activator and that levels of the enzyme correlate with disease activity. We will: 1. Characterize the mechanism for increases in plasminogen activator activity in psoriasis which involves determining whether there is increased synthesis of plasminogen activator enzyme, increased activation of plasminogen activator zymogen, or decreased in plasminogen activator inhibitor in psoriasis. 2. Explore the effects of plasminogen activator on epidermal cell replication. 3. Investigate whether plasminogen activator or plasmin is the active principle which attracts polymorphonuclear leukocytes to the psoriatic epidermis. We will also study whether proteinases play a role in polymorph accumulation in epidermal injury from toxins. We have identified a thiol proteinase, operative at neutral pH, in epithelium. This proteinase is capable of degrading epidermal cell surface proteins. We will purify and characterize this proteinase and determine its role in epidermal physiology.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM032070-04
Application #
3152415
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1982-08-01
Project End
1989-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Baird, J; Lazarus, G S; Belin, D et al. (1990) mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548-52
Harvima, I T; Schechter, N M; Harvima, R J et al. (1988) Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta 957:71-80
Schechter, N M; Slavin, D; Fetter, R D et al. (1988) Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase. Arch Biochem Biophys 262:232-44
Jensen, P J; Baird, J; Morioka, S et al. (1988) Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90:777-82
Craig, S S; Schechter, N M; Schwartz, L B (1988) Ultrastructural analysis of human T and TC mast cells identified by immunoelectron microscopy. Lab Invest 58:682-91
Sayama, S; Iozzo, R V; Lazarus, G S et al. (1987) Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J Biol Chem 262:6808-15
Schwartz, L B; Irani, A M; Roller, K et al. (1987) Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J Immunol 138:2611-5
Morioka, S; Lazarus, G S; Jensen, P J (1987) Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. J Invest Dermatol 89:474-7
Irani, A M; Craig, S S; DeBlois, G et al. (1987) Deficiency of the tryptase-positive, chymase-negative mast cell type in gastrointestinal mucosa of patients with defective T lymphocyte function. J Immunol 138:4381-6
Schechter, N M; Choi, J K; Slavin, D A et al. (1986) Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol 137:962-70

Showing the most recent 10 out of 18 publications